Chin K相关文献与解析，生知库 | 链接生命科学的每一步

日期影响因子

Semiquantitative CLDN18 expression and clinical outcomes in patients with CLDN18-positive gastric cancer treated with zolbetuximab plus chemotherapy

半定量CLDN18表达与接受佐贝妥昔单抗联合化疗治疗的CLDN18阳性胃癌患者的临床结局

doi:10.1016/j.esmogo.2026.100304

Ooki, A; Nakano, K; Shimozaki, K; Takamatsu, M; Fukuoka, S; Sakata, S; Osumi, H; Yoshikawa, K; Toyokawa, E; Yoshino, K; Udagawa, S; Wakatsuki, T; Ogura, M; Shinozaki, E; Chin, K; Kawachi, H; Yamaguchi, K

发表日期：2026

文献求助收藏

BevRam-GC01 study protocol: a phase I trial of bevacizumab plus ramucirumab and paclitaxel in advanced gastric cancer

BevRam-GC01 研究方案：贝伐珠单抗联合雷莫芦单抗和紫杉醇治疗晚期胃癌的 I 期临床试验

doi:10.1016/j.esmogo.2025.100299

Wakatsuki, T; Mashima, T; Miyazaki, N; Osumi, H; Fukuoka, S; Ooki, A; Shimozaki, K; Ogura, M; Yoshino, K; Udagawa, S; Shinozaki, E; Chin, K; Ishida, N; Seimiya, H; Yamaguchi, K

发表日期：2026

文献求助收藏

Phase II trial of enfortumab vedotin in patients with previously treated gastric and esophageal cancers

恩福妥单抗治疗既往接受过治疗的胃癌和食管癌患者的II期临床试验

期刊:ESMO Open

影响因子:8.3

doi:10.1016/j.esmoop.2025.105806

Muro, K; Chin, K; Maron, S B; Braiteh, F S; Mitani, S; Hara, H; Kuboki, Y; Mulcahy, M F; Baranda, J C; Gardner, F P; Jin, N; Hamauchi, S; Kaplan, J; Gorla, S; Liu, S; Wozniak, M; Poondru, S; Dillon, R; Meng, C; Kondo, S

发表日期：2025

文献求助收藏

Rotational Thromboelastometry Reduces the Need for Preemptive Transfusion in Cirrhosis: A Randomized Controlled Trial (NCT:05698134)

旋转血栓弹力图可减少肝硬化患者预防性输血的需求：一项随机对照试验（NCT:05698134）

期刊:Journal of Clinical and Experimental Hepatology

影响因子:3.2

doi:10.1016/j.jceh.2024.102409

Kumar, Rahul; Ng, Louis X L; Wong, Yu J; Tan, Chin K; Wang, Louis Z; Qiu, Tian Y; Wong, Benny; Lin, Kenneth W; Li, James W; Kwek, Andrew B E; Ang, Tiing L; Gokhle, Roshni S; Sivanath, Tirukonda P

发表日期：2025

文献求助收藏

Biodistribution studies of (89)Zr-Labeled stem cell-derived exosomes using PET imaging

利用PET成像技术研究(89)Zr标记的干细胞来源外泌体的生物分布

期刊:Applied Radiation and Isotopes

影响因子:1.8

doi:10.1016/j.apradiso.2025.112000

Li, Junling; Li, Chi; Zheng, Huaiyu; Yaddanapudi, Kavitha; Ng, Chin K

细胞生物学

发育与干细胞

发表日期：2025

文献求助收藏

The clinical utility of an mGPS and SII combined score in patients with advanced gastric cancer treated with nivolumab monotherapy

mGPS 和 SII 联合评分在接受纳武利尤单抗单药治疗的晚期胃癌患者中的临床应用价值

doi:10.1016/j.esmogo.2025.100177

Udagawa, S; Ooki, A; Osumi, H; Yoshino, K; Tamba, M; Shimozaki, K; Fukuoka, S; Wakatsuki, T; Ogura, M; Shinozaki, E; Chin, K; Yamaguchi, K

发表日期：2025

文献求助收藏

Real-world clinical impact of first-line immune checkpoint inhibitor-based therapy in advanced esophageal squamous cell carcinoma

一线免疫检查点抑制剂疗法在晚期食管鳞状细胞癌中的真实临床影响

doi:10.1016/j.esmogo.2025.100171

Tamba, M; Chin, K; Osumi, H; Ogura, M; Fukuoka, S; Udagawa, S; Shimozaki, K; Yoshino, K; Wakatsuki, T; Shinozaki, E; Yamaguchi, K; Ooki, A

细胞生物学

免疫/内分泌

发表日期：2025

文献求助收藏

Clinical efficacy of nivolumab-based therapy for HER2-negative diffuse-type advanced gastric or gastroesophageal junction adenocarcinoma with peritoneal dissemination

纳武利尤单抗治疗伴有腹膜播散的HER2阴性弥漫型晚期胃癌或胃食管交界处腺癌的临床疗效

doi:10.1016/j.esmogo.2025.100143

Suzuki, Y; Shimozaki, K; Udagawa, S; Chin, K; Osumi, H; Fukuoka, S; Yoshino, K; Tamba, M; Wakatsuki, T; Ogura, M; Shinozaki, E; Yamaguchi, K; Ooki, A

发表日期：2025

文献求助收藏

Managing zolbetuximab-induced nausea and vomiting: a proposal for a pragmatic approach in clinical practice

佐贝妥昔单抗引起的恶心和呕吐的管理：临床实践中一种务实的治疗方法

doi:10.1016/j.esmogo.2024.100128

Shimozaki, K; Ooki, A; Yamahata, Y; Aoyama, T; Yoshino, K; Tamba, M; Udagawa, S; Fukuoka, S; Osumi, H; Wakatsuki, T; Shinozaki, E; Ogura, M; Chin, K; Yamaguchi, K

发表日期：2025

文献求助收藏

Prognostic nutritional index as a prognostic marker in metastatic esophageal squamous-cell carcinoma treated with immune checkpoint inhibitor

预后营养指数作为免疫检查点抑制剂治疗转移性食管鳞状细胞癌的预后标志物

doi:10.1016/j.esmogo.2025.100222

Yoshino, K; Tamba, M; Osumi, H; Fukuoka, S; Ogura, M; Udagawa, S; Shimozaki, K; Wakatsuki, T; Shinozaki, E; Yamaguchi, K; Chin, K; Ooki, A

细胞生物学

免疫/内分泌

发表日期：2025

文献求助收藏